Airbus says 500 A321neos can keep flying, but can it still hit its delivery target?

Airbus SE (Euronext Paris: AIR) is dealing with another supplier-related quality problem in its narrow-body production system after identifying an incorrectly applied anti-corrosion primer on structural components inside the forward fuselage of a batch of A321neo aircraft. Reuters reported that roughly 500 aircraft may be affected, including about 250 already in service and another 250 in production, while Airbus has emphasised that the aircraft can continue operating because the defect is classified as a quality issue rather than an immediate safety risk.

The defect involves surface protection on fuselage stringers, structural members that help reinforce the aircraft. Reuters reported, citing industry sources, that the problem originated in the Italian supply chain and involved work performed by a subcontractor associated with Leonardo S.p.A., one of the aerostructure suppliers feeding Airbus’ A321neo programme. Airbus said the source had been identified and contained and that a remedy was available.

Airbus shares fell around 1% on September 25 after the issue became public, reflecting investor concern less about an immediate safety event than about another potential complication for deliveries. That distinction is crucial because the A321neo is one of Airbus’ most commercially important aircraft and the manufacturer is already working through a demanding production ramp-up.

Why does an A321neo primer problem matter if Airbus says the aircraft are safe?

Aircraft manufacturing economics are unforgiving even when a defect does not ground planes. A quality deviation may require inspections, documentation, rework, coordination with suppliers and discussions with airline customers about when corrective work will be performed. Each of those steps consumes engineering time and production capacity that could otherwise be dedicated to accelerating deliveries.

Airbus has said the existing fleet can continue flying and that a repair has been identified. Reuters reported that the issue could reduce corrosion resistance if left unaddressed, meaning the concern relates to long-term structural protection rather than an immediate flight-safety hazard. The A321XLR, the longer-range derivative that Airbus is using to extend the single-aisle family into thinner long-haul routes, was not affected according to a source cited by Reuters.

That should limit the operational severity for airlines, but it does not eliminate manufacturing consequences. Roughly half of the potentially affected aircraft were still within Airbus’ production system when the problem emerged, according to Reuters. Reworking aircraft before delivery can disrupt factory sequencing even when the physical repair itself is manageable.

The commercial importance of the aircraft amplifies that risk. The A321neo has become the largest member of Airbus’ A320neo family and has substantially outsold the largest variants of Boeing’s 737 MAX family. Every production interruption therefore touches a programme that sits at the centre of Airbus’ competitive advantage in the single-aisle market.

Can Airbus still deliver around 870 commercial aircraft in 2026?

Airbus is maintaining its target of roughly 870 commercial-aircraft deliveries for 2026. The company delivered 351 commercial aircraft during the first half and had reached 475 deliveries by the end of August, according to Airbus and Reuters. That means a large share of the full-year target remains concentrated in the final months, as is common in aerospace but still operationally demanding.

At its half-year results, Airbus reported €33.2 billion of revenue and €2.7 billion of adjusted EBIT while reaffirming guidance for approximately €7.5 billion of adjusted EBIT and €4.5 billion of free cash flow before customer financing. The guidance explicitly assumed no additional material disruptions to supply chains, internal operations or the company’s ability to deliver products and services.

That assumption is what makes the new defect important. The primer issue may ultimately prove manageable, but it arrives during a period when Airbus has limited tolerance for additional friction. Reuters reported that the company is attempting to increase narrow-body production toward 75 aircraft per month from roughly 60, requiring thousands of suppliers to increase output while maintaining aerospace quality standards.

Manufacturing at that scale creates a difficult balance. Airbus needs suppliers to accelerate, but faster production can expose weak points in processes that were stable at lower volumes. Quality assurance therefore becomes more important, not less, as production rates increase.

Why is this Airbus quality issue drawing comparisons with the 2025 fuselage problem?

The sensitivity partly reflects recent history. Reuters noted that Airbus encountered another fuselage-panel quality issue in late 2025 involving a Spanish supplier. Although that problem was also treated as a quality matter rather than an immediate safety threat, resolving it contributed to delivery disruption and helped push Airbus below its original 2025 delivery ambition.

The latest defect is described as less severe, and Airbus has already identified a remedy. That is encouraging operationally, but investors are likely to focus on the recurrence of supplier-quality issues within less than a year.

The question is not whether the two defects have the same technical cause; available evidence says they do not. The more relevant question is whether Airbus’ production system can increase output while detecting supplier deviations early enough to prevent them from accumulating across hundreds of aircraft.

Commercial aerospace supply chains are unusually complex because airframes incorporate structures, systems and components produced across many countries before final assembly. Airbus therefore controls programme design and ultimate quality responsibility while relying on supplier manufacturing processes that it does not physically perform itself.

This is why a relatively narrow technical problem can become a broader execution issue. The cost of rework may be manageable, but the risk is that aircraft move through several production stages before a deviation is detected, making correction more disruptive.

What does the A321neo mean for the Airbus versus Boeing competition?

The A321neo occupies a strategically valuable segment between conventional short-haul narrow-body aircraft and smaller wide-body missions. Airlines use the model for high-density routes, longer transcontinental sectors and markets where the aircraft’s range and seat economics allow carriers to open routes that might not support a larger twin-aisle jet.

That positioning has given Airbus an important advantage in the upper end of the single-aisle market. Boeing has no direct new-generation replacement for the discontinued 757, and the largest 737 MAX variants have faced their own certification and production challenges.

Airbus therefore has a powerful incentive to protect A321neo delivery momentum. Every aircraft delayed represents not merely deferred revenue but potentially additional frustration for carriers already planning fleets years in advance.

Airlines themselves have limited alternatives in the near term because order backlogs across the commercial aerospace industry stretch for years. A customer cannot easily switch hundreds of aircraft from Airbus to Boeing or vice versa without disrupting fleet planning, pilot training, maintenance systems and route economics. That reduces immediate cancellation risk but increases pressure on manufacturers to deliver what has already been sold.

What is the financial risk from the A321neo rework?

Airbus has not disclosed a cost estimate for the latest defect, so attaching a specific financial figure would be premature. The economic effect will depend on how much work each aircraft requires, whether corrections are performed before delivery or during future maintenance, how costs are shared through the supply chain and whether any customer concessions become necessary.

Reuters reported that airlines may receive arrangements connected with future maintenance, but the available reporting does not suggest a wholesale grounding or suspension of A321neo deliveries. That difference sharply limits the potential severity compared with a safety-related fleet action.

Investors should instead monitor delivery data. If Airbus continues progressing toward approximately 870 aircraft and avoids a substantial build-up of completed but undeliverable jets, the defect may ultimately become a contained manufacturing expense. If monthly deliveries weaken while rework accumulates, concern would shift toward cash flow because commercial aircraft manufacturers typically receive a substantial portion of customer payments around delivery.

That is especially relevant after Airbus reported negative €1.17 billion of free cash flow before customer financing during the first half, partly because inventory was being built to support higher production. The company expects that working capital to convert as aircraft are completed and handed to customers.

What does Airbus stock sentiment say after the latest quality issue?

Airbus shares were down around 1% on September 25, a noticeable but contained reaction. The movement suggests investors treated the news as another execution risk rather than evidence of a fundamental safety crisis or structural problem with demand.

That interpretation is reasonable based on currently disclosed facts. Airbus has said the aircraft remain safe to operate, the source has been contained, a repair exists and full-year guidance remains unchanged. At the same time, the company still has to demonstrate that those assurances translate into actual deliveries over the fourth quarter.

The analytical issue is therefore less dramatic than the phrase “500 affected aircraft” initially sounds, but more significant than a routine cosmetic manufacturing defect. The A321neo is strategically vital, Airbus is already operating against an ambitious year-end delivery schedule and this is the second notable fuselage-related quality-control episode in less than a year.

The strongest evidence will arrive not through additional statements but through delivery numbers. If Airbus can repair aircraft without materially disrupting factory flow, the share-price impact may remain limited. If the defect becomes another bottleneck in an already stretched supply chain, the 870-aircraft target could again become the market’s central focus.